Sign in
Taking people in United StatesNo phase

Pipeline Flex device with Shield Technology for wide-necked brain aneurysms

Tests a flow diverter device for treating wide-necked brain aneurysms in adults.

Key facts

Who runs it
Jacobs institute
Where
Buffalo, United StatesSee the site
Trial code
Registry title
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
Status
Recruiting
People taking part
10 people, planned
Started
1 Jan 2025
Expected to end
1 Jan 2027
Type of study
Interventional
Treatments tested
  • SHIELD
Record updated
10 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a large or giant wide-necked brain aneurysm in the internal carotid artery. They will be treated with the Pipeline Flex Embolization Device with Shield Technology.

Age
22 years or older
Sex
All sexes can join
Disease stage
Large or giant wide-necked intracranial aneurysm (a bulging blood vessel in the brain) in the internal carotid artery, from the petrous to the superior hypophyseal segments.

Main reasons for not taking part

  • People who cannot give consent and have no legal representative to give it cannot join.

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms (IAs) in the internal carotid artery from the petrous to the superior hypophyseal segments

Who cannot take part

  • Cannot provide consent or legally authorized representative not available to provide consent Criteria:

Where in United States

  • Jacobs InstituteBuffalo, United StatesContact: Carlos Pena, PhD, MSTaking people

About the trial

What the trial wants to find out

The Jacobs Institute is participating in a study designed to collect prospective clinical evidence to evaluate the approved use of the Pipeline™ Flex Embolization Device with Shield Technology™ for the endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms

The group in the trial

  • SHIELD Study ArmOther group

    Active treatment with the Pipeline SHIELD Device

    Treatment: SHIELD

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
Plain-language title
Pipeline Flex device with Shield Technology for wide-necked brain aneurysmsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
10 March 2026